The global burden of lung cancer: current status and future trends

被引:0
|
作者
Amanda Leiter
Rajwanth R. Veluswamy
Juan P. Wisnivesky
机构
[1] Icahn School of Medicine at Mount Sinai,Division of Endocrinology, Diabetes, and Bone Diseases, Department of Medicine
[2] Icahn School of Medicine at Mount Sinai,Division of Hematology and Oncology, Department of Medicine
[3] Icahn School of Medicine at Mount Sinai,Division of General Internal Medicine, Department of Medicine
[4] Icahn School of Medicine at Mount Sinai,Tisch Cancer Institute
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Lung cancer is the leading cause of cancer-related death worldwide. However, lung cancer incidence and mortality rates differ substantially across the world, reflecting varying patterns of tobacco smoking, exposure to environmental risk factors and genetics. Tobacco smoking is the leading risk factor for lung cancer. Lung cancer incidence largely reflects trends in smoking patterns, which generally vary by sex and economic development. For this reason, tobacco control campaigns are a central part of global strategies designed to reduce lung cancer mortality. Environmental and occupational lung cancer risk factors, such as unprocessed biomass fuels, asbestos, arsenic and radon, can also contribute to lung cancer incidence in certain parts of the world. Over the past decade, large-cohort clinical studies have established that low-dose CT screening reduces lung cancer mortality, largely owing to increased diagnosis and treatment at earlier disease stages. These data have led to recommendations that individuals with a high risk of lung cancer undergo screening in several economically developed countries and increased implementation of screening worldwide. In this Review, we provide an overview of the global epidemiology of lung cancer. Lung cancer risk factors and global risk reduction efforts are also discussed. Finally, we summarize lung cancer screening policies and their implementation worldwide.
引用
收藏
页码:624 / 639
页数:15
相关论文
共 50 条
  • [1] The global burden of lung cancer: current status and future trends
    Leiter, Amanda
    Veluswamy, Rajwanth R.
    Wisnivesky, Juan P.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2023, 20 (09) : 624 - 639
  • [2] Current status and future trends of the global burden of MASLD
    Miao, Lei
    Targher, Giovanni
    Byrne, Christopher D.
    Cao, Ying-Ying
    Zheng, Ming-Hua
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2024, 35 (08): : 697 - 707
  • [3] Global burden and trends of lung cancer incidence and mortality
    Li, Chao
    Lei, Shaoyuan
    Ding, Li
    Xu, Yan
    Wu, Xiaonan
    Wang, Hui
    Zhang, Zijin
    Gao, Ting
    Zhang, Yongqiang
    Li, Lin
    [J]. CHINESE MEDICAL JOURNAL, 2023, 136 (13) : 1583 - 1590
  • [4] Global burden and trends of lung cancer incidence and mortality
    Li Chao
    Lei Shaoyuan
    Ding Li
    Xu Yan
    Wu Xiaonan
    Wang Hui
    Zhang Zijin
    Gao Ting
    Zhang Yongqiang
    Li Lin
    [J]. 中华医学杂志(英文版), 2023, 136 (13)
  • [5] Current Status and Future of Immunotherapy in Lung Cancer
    Reck, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1606 - S1607
  • [6] Ultrasound in breast cancer: current status and future trends
    Otto, R.
    [J]. EJC SUPPLEMENTS, 2004, 2 (03): : 40 - 41
  • [7] Current status and future trends in cervical cancer screening
    Castle, Philip
    [J]. WOMENS HEALTH, 2014, 10 (02) : 129 - 133
  • [8] Ultrasound in breast cancer: current status and future trends
    不详
    [J]. EJC SUPPLEMENTS, 2006, 4 (02): : 28 - 28
  • [9] Radon and Lung Cancer: Current Trends and Future Perspectives
    Riudavets, Mariona
    Garcia de Herreros, Marta
    Besse, Benjamin
    Mezquita, Laura
    [J]. CANCERS, 2022, 14 (13)
  • [10] Current status and future perspectives of immunotherapy in lung cancer
    Yoshida, Tatsuya
    [J]. CANCER SCIENCE, 2023, 114 : 1765 - 1765